A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
A new clinical trial suggests that donepezil does not improve cognitive performance in people with mild cognitive impairment who also have clinical depression.
A new National Academies report—co-authored by Columbia Nursing’s Suzanne Bakken—recommends returning health information gathered during research to study participants.
Columbia scientists have developed a new computational framework that can support precision cancer treatment by matching individual tumors with the drugs most likely to kill them.
Four physician-scientists at the Vagelos College of Physicians and Surgeons have been named 2018 Gerstner Scholars and a fifth has been named a Gerstner Merit Awardee.
Lorraine S. Symington, PhD, the Harold S. Ginsberg Professor of Microbiology & Immunology, has been elected to the American Academy of Arts and Sciences.